| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/22/1997 | US5650439 Treatment of parkinson*s disease |
| 07/22/1997 | US5650438 Process for activating reproduction in seasonal breeding animals by administering L-dihydroxyphenylalanine (L-dopa) |
| 07/22/1997 | US5650437 Method of using benzilic acid for treating wrinkles |
| 07/22/1997 | US5650436 Method of using galactonic acid or galactonolactone for treating wrinkles |
| 07/22/1997 | US5650435 Modulation of inflammation related to columnar epithelia |
| 07/22/1997 | US5650433 Chondroprotective agents |
| 07/22/1997 | US5650432 Proanthocyanidins |
| 07/22/1997 | US5650429 Use of DL-(+/-)-α-lipoic acid, D-(+)-α-lipoic acid, α-lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 07/22/1997 | US5650427 Antidepressants |
| 07/22/1997 | US5650426 Enantiomers of carbazole derivatives as 5-HT.sub. 1-like agonists |
| 07/22/1997 | US5650425 Anticarcinogenic, antagonist, antitumor agents and antiinflammatory agents |
| 07/22/1997 | US5650424 Antiagglomerants using imidazolidindiones |
| 07/22/1997 | US5650422 Treatment of emphysema, arthritis or pancreatitis |
| 07/22/1997 | US5650421 Premixed famotidine formulation |
| 07/22/1997 | US5650420 Pramipexole as a neuroprotective agent |
| 07/22/1997 | US5650419 Thiadiazoles and their use as antipicornaviral agents |
| 07/22/1997 | US5650418 Ascorbic acid or salt, nicotinic acid, cardiovascular disorders |
| 07/22/1997 | US5650417 Substituted pyridines, their preparation, and their use as pesticides and fungicides |
| 07/22/1997 | US5650416 Piperidinyl thiacyclic derivatives |
| 07/22/1997 | US5650415 Quinoline compounds |
| 07/22/1997 | US5650414 Pyrazolopyridines or imidazolopyridines |
| 07/22/1997 | US5650413 Enzyme inhibitors and antitumor agents |
| 07/22/1997 | US5650411 Substituted azolone derivatives |
| 07/22/1997 | US5650409 Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| 07/22/1997 | US5650408 Thiazolo benzazepine containing dual action inhibitors |
| 07/22/1997 | US5650405 Treatment for toxoplasmosis with a composition comprising a sulfonamide and a spiropiperidyl derivative of rifamycin S. |
| 07/22/1997 | US5650404 Phosphoric diester phospholipase a2 inhibitor |
| 07/22/1997 | US5650397 Polyether antibiotic with nitro-p-diaminobenzene and benzimidazole |
| 07/22/1997 | US5650394 Use of urinastatin-like compounds to prevent premature delivery |
| 07/22/1997 | US5650386 Compositions for oral delivery of active agents |
| 07/22/1997 | US5650293 Nucleic acid encoding pp60PIK and the methods of making pp60PIK |
| 07/22/1997 | US5650292 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 07/22/1997 | US5650282 Genes and chromosomes for prevention and detection of vascular stenosis |
| 07/22/1997 | US5650271 Primers and templates, extenders and hybrids |
| 07/22/1997 | US5650174 Alkaloid ether methyloxime salt |
| 07/22/1997 | US5650171 Retinoic acid-containing polyether-polyurethane compositions |
| 07/22/1997 | US5650168 Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance |
| 07/22/1997 | US5650167 Viricides for hepatitis |
| 07/22/1997 | US5650158 Moisture-regulating composition for cosmetics or dermatology |
| 07/22/1997 | US5650157 Pharmaceutical compositions and methods |
| 07/22/1997 | US5650155 Tocols as adjuvant in vaccine |
| 07/22/1997 | US5650145 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith |
| 07/22/1997 | CA2047236C Substituted 3-amino chromans |
| 07/22/1997 | CA2020923C Urethane derivative, their preparation and their applications as hydrating agents in cosmetic or pharmaceutical compositions for the treatment of dry skin |
| 07/22/1997 | CA2001552C Cyclophosphamide - sodium bicarbonate lyophilizates |
| 07/19/1997 | CA2195177A1 Heteroatom-containing cyclopentanopyridyl-oxazolidinones |
| 07/18/1997 | CA2195371A1 Immunosuppressive-activity potentiating compositions |
| 07/17/1997 | WO1999025331A1 Use of ketoacids together with amino acids for enhancing muscle performance and recovery from fatigue |
| 07/17/1997 | WO1997025443A1 Metastasis inducing dna's |
| 07/17/1997 | WO1997025440A2 Methods and compositions for diagnosis of hyperhomocysteinemia |
| 07/17/1997 | WO1997025430A1 Calcium binding proteolipid compositions and methods |
| 07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
| 07/17/1997 | WO1997025424A1 Ob protein receptor and related compositions and methods |
| 07/17/1997 | WO1997025421A2 PROTEIN INDUCED BY DEPRENYL$m(3) |
| 07/17/1997 | WO1997025418A1 Angiotensin converting enzyme inhibitors |
| 07/17/1997 | WO1997025404A1 Disinfecting compositions and processes for disinfecting surfaces |
| 07/17/1997 | WO1997025352A1 PROCESS FOR ISOLATING IgG AND IgA |
| 07/17/1997 | WO1997025351A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 07/17/1997 | WO1997025343A2 Antithrombotic agents and methods of use |
| 07/17/1997 | WO1997025342A1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione |
| 07/17/1997 | WO1997025339A1 Composition and method for delivery of nucleic acids |
| 07/17/1997 | WO1997025337A1 Therapeutic compounds |
| 07/17/1997 | WO1997025333A2 Macrocyclic compounds made from suboxide units |
| 07/17/1997 | WO1997025332A1 Hexacyclic camptothecin analogues, and process for preparing them |
| 07/17/1997 | WO1997025331A1 Heterocycle-condensed morphinoid derivatives (ii) |
| 07/17/1997 | WO1997025328A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF, INTERMEDIATES THEREOF AND DRUGS CONTAINING SAME |
| 07/17/1997 | WO1997025324A1 Substituted aza- and diazacycloheptane and cyclooctane compounds and their use |
| 07/17/1997 | WO1997025323A1 Fibrinogen receptor antagonists |
| 07/17/1997 | WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 07/17/1997 | WO1997025321A2 Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
| 07/17/1997 | WO1997025317A1 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity |
| 07/17/1997 | WO1997025316A1 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity |
| 07/17/1997 | WO1997025315A1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
| 07/17/1997 | WO1997025313A1 New manufacturing process |
| 07/17/1997 | WO1997025311A1 Novel tricyclic compounds and drug compositions containing the same |
| 07/17/1997 | WO1997025309A1 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 07/17/1997 | WO1997025305A1 Novel monofunctionalised edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy |
| 07/17/1997 | WO1997025106A1 Disinfecting compositions and processes for disinfecting surfaces |
| 07/17/1997 | WO1997025077A1 SKIN-ADHERING PHARMACEUTICAL PREPARATION, IN PARTICULAR TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-β-ESTRADIOL TO THE HUMAN ORGANISM |
| 07/17/1997 | WO1997025071A2 Immunoconjugate for the treatment of aids |
| 07/17/1997 | WO1997025069A1 Antibodies with reduced net positive charge |
| 07/17/1997 | WO1997025068A2 Mesothelin antigen and methods and kits for targeting it |
| 07/17/1997 | WO1997025067A2 Polymers |
| 07/17/1997 | WO1997025066A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 07/17/1997 | WO1997025065A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
| 07/17/1997 | WO1997025064A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid |
| 07/17/1997 | WO1997025061A1 De-myristolated lipopolysaccharide of gram-negative bacteria |
| 07/17/1997 | WO1997025060A1 Amino acid compositions |
| 07/17/1997 | WO1997025059A1 Using serine-proteases for acne and inflamed comedones |
| 07/17/1997 | WO1997025057A1 Aqueous prolonged release formulation |
| 07/17/1997 | WO1997025055A1 Nisin in combination with glycerol monolaurate active against helicobacter |
| 07/17/1997 | WO1997025052A2 Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons |
| 07/17/1997 | WO1997025051A1 Oral administration of effective amounts of forms of hyaluronic acid |
| 07/17/1997 | WO1997025049A1 Composition containing diosgenin |
| 07/17/1997 | WO1997025048A1 Novel cycloalkyl substituted imidazoles |
| 07/17/1997 | WO1997025047A1 Novel cycloalkyl substituded imidazoles |
| 07/17/1997 | WO1997025046A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025045A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025044A1 Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy |
| 07/17/1997 | WO1997025043A1 A method of treating hypercholesterolemia and related disorders |